|4Dec 21, 3:22 PM ET

Capstone Therapeutics Corp. 4

4 · Capstone Therapeutics Corp. · Filed Dec 21, 2010

Insider Transaction Report

Form 4
Period: 2010-12-20
HOLLIMAN JOHN M III
DirectorExecutive Chairman
Transactions
  • Purchase

    Common Stock

    2010-12-20$0.47/sh+25,000$11,750247,614 total
  • Purchase

    Common Stock

    2010-12-21$0.45/sh+25,000$11,250272,614 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,000
  • Common Stock

    (indirect: Valley Ventures III, LP)
    1,658

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES